These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 2147597

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Nafarelin versus danazol in the treatment of endometriosis.
    Rolland R, van der Heijden PF.
    Am J Obstet Gynecol; 1990 Feb; 162(2):586-8. PubMed ID: 2137976
    [Abstract] [Full Text] [Related]

  • 6. Evidence of similar increases in bone turnover during nafarelin and danazol use in women with endometriosis.
    Ylikorkala O, Nilsson CG, Hirvonen E, Viinikka L.
    Gynecol Endocrinol; 1990 Dec; 4(4):251-60. PubMed ID: 2150580
    [Abstract] [Full Text] [Related]

  • 7. Nafarelin for endometriosis: a large-scale, danazol-controlled trial of efficacy and safety, with 1-year follow-up. The Nafarelin European Endometriosis Trial Group (NEET).
    Fertil Steril; 1992 Mar; 57(3):514-22. PubMed ID: 1531464
    [Abstract] [Full Text] [Related]

  • 8. A comparative treatment trial of endometriosis using the gonadotrophin-releasing hormone agonist, nafarelin, and the synthetic steroid, danazol.
    Fraser IS, Shearman RP, Jansen RP, Sutherland PD.
    Aust N Z J Obstet Gynaecol; 1991 May; 31(2):158-63. PubMed ID: 1834049
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Metabolic changes during medical treatment of endometriosis: nafarelin acetate versus danazol.
    Burry KA, Patton PE, Illingworth DR.
    Am J Obstet Gynecol; 1989 Jun; 160(6):1454-9; discussion 1459-61. PubMed ID: 2525337
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacologic management of endometriosis.
    Saltiel E, Garabedian-Ruffalo SM.
    Clin Pharm; 1991 Jul; 10(7):518-31. PubMed ID: 1830521
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. On the origin and significance of serum CA-125 concentrations in 97 patients with endometriosis before, during, and after buserelin acetate, nafarelin, or danazol.
    Franssen AM, van der Heijden PF, Thomas CM, Doesburg WH, Willemsen WN, Rolland R.
    Fertil Steril; 1992 May; 57(5):974-9. PubMed ID: 1533376
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.